Company: PTPI
Filing Date: 2025-03-18
Form Type: DEF 14A
Source: 0001104659-25-025104
Chunk: 41

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-18
Form: DEF 14A
Chunk 41
---
 the specific
Reverse Stock Split ratio will be based on several factors, including, among other things:

| · | our ability to maintain the listing of our Common Stock on The Nasdaq Capital Market; |

| · | the per share price of our Common Stock immediately prior to the Reverse Stock Split; |

| · | the expected stability of the per share price of our Common Stock following the Reverse Stock Split; |

| · | the likelihood that the Reverse Stock Split will result in increased marketability and liquidity of our Common Stock; |

| · | prevailing market conditions; |

<div align='center'>25</div>

| · | general economic conditions in our industry; and |

| · | our market capitalization before and after the Reverse Stock Split. |

We believe that granting
our Board the authority to set the ratio for the Reverse Stock Split is essential because it allows us to take these factors into consideration
and to react to changing market conditions. If the Board chooses to implement the Reverse Stock Split, the Company will make a public
announcement regarding the determination of the Reverse Stock Split ratio.

Board Discretion to Effect the Reverse Stock Split

If the Reverse Stock Split
proposal is approved by our stockholders, the Board will have the discretion to implement the Reverse Stock Split or to not effect the
Reverse Stock Split at all. The Board currently intends to effect the Reverse Stock Split. If the trading price of our Common Stock increases
without effecting the Reverse Stock Split, the Reverse Stock Split may not be necessary. Following the Reverse Stock Split, if implemented,
there can be no assurance that the market price of our Common Stock will rise in proportion to the reduction in the number of outstanding
shares resulting from the Reverse Stock Split or that the market price of the post-split Common Stock can be maintained above $1.00. There
also can be no assurance that our Common Stock will not be delisted from Nasdaq for other reasons.

If our stockholders approve
the Reverse Stock Split proposal at the Special Meeting, the Reverse Stock Split will be effected, if at all, only upon a determination
by the Board that the Reverse Stock Split is in the best interests of the Company and its stockholders at that time. No further action
on the part of the stockholders will be required to either effect or abandon the Reverse Stock Split. If our Board does not implement
the Reverse Stock Split prior to the one-year anniversary of the date on which the reverse stock split is approved by the Company’s
stockholders at the Special Meeting,